 Connection
John Rumsfeld to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications John Rumsfeld has written about Platelet Aggregation Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.006 |
|
|
|
-
Maddox TM, Ho PM, Tsai TT, Wang TY, Li S, Peng SA, Wiviott SD, Masoudi FA, Rumsfeld JS. Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Jul 01; 5(4):523-31.
Score: 0.310
-
Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009 Mar 04; 301(9):937-44.
Score: 0.249
-
Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008 Feb 06; 299(5):532-9.
Score: 0.231
-
Ho PM, Fihn SD, Wang L, Bryson CL, Lowy E, Maynard C, Magid DJ, Peterson ED, Jesse RL, Rumsfeld JS. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J. 2007 Nov; 154(5):846-51.
Score: 0.227
-
Sherwood MW, Vemulapalli S, Harrison JK, Dai D, Vora AN, Mack MJ, Holmes DR, Rumsfeld JS, Cohen DJ, Thourani VH, Kirtane A, Peterson ED. Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry. Am Heart J. 2018 10; 204:9-16.
Score: 0.119
-
Aggarwal V, Armstrong EJ, Liu W, Maddox TM, Ho PM, Carey E, Wang T, Sherwood M, Tsai TT, Rumsfeld JS, Bradley SM. Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program. Clin Cardiol. 2016 Oct; 39(10):578-584.
Score: 0.105
-
Barnes GD, Stanislawski MA, Liu W, Bar?n AE, Armstrong EJ, Ho PM, Klein A, Maddox TM, Nallamothu BK, Rumsfeld JS, Tsai TT, Bradley SM. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2016 07; 9(4):406-13.
Score: 0.103
-
Vigen R, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM. Hospital Variation in Premature Clopidogrel Discontinuation After Drug-Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System. J Am Heart Assoc. 2016 05 05; 5(5).
Score: 0.102
-
Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):96-102.
Score: 0.092
-
Byrd JB, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM. Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program. Am Heart J. 2014 Sep; 168(3):340-5.
Score: 0.090
-
Kim MS, Wang TY, Ou FS, Klein AJ, Hudson PA, Messenger JC, Masoudi FA, Rumsfeld JS, Ho PM. Association of prior coronary artery bypass graft surgery with quality of care of patients with non-ST-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines. Am Heart J. 2010 Nov; 160(5):951-7.
Score: 0.070
-
Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):261-6.
Score: 0.067
-
Ho PM, Tsai TT, Wang TY, Shetterly SM, Clarke CL, Go AS, Sedrakyan A, Rumsfeld JS, Peterson ED, Magid DJ. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
Score: 0.067
-
Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS, Spertus JA, Peterson ED. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation. 2008 Nov 18; 118(21):2139-45.
Score: 0.061
-
Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006 Jun 20; 113(24):2803-9.
Score: 0.052
-
Navarro MA, Gosch KL, Spertus JA, Rumsfeld JS, Ho PM. Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction. J Am Heart Assoc. 2016 05 23; 5(5).
Score: 0.026
-
Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med. 2012 Aug 13; 172(15):1145-52.
Score: 0.020
-
Melloni C, Alexander KP, Ou FS, LaPointe NM, Roe MT, Newby LK, Baloch K, Ho PM, Rumsfeld JS, Peterson ED. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol. 2009 Jul 15; 104(2):175-81.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|